A systematic review of the effects of polyols on gastrointestinal health and irritable bowel syndrome

Advances in Nutrition

Volumn 8, Issue 4, 2017, Pages 587-596

  Lenhart, Adrienne ^a   Chey, William D ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Artificial sweeteners; Disaccharides; Fermentable oligosaccharides; Microbiome; Monosaccharides; Motility; Polyols; Sugar alcohols

Indexed keywords

POLYMER; POLYOL;

DRUG EFFECTS; FRUIT; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MALABSORPTION; METABOLISM; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VEGETABLE;

FRUIT; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; MALABSORPTION SYNDROMES; POLYMERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VEGETABLES;

EID: 85024367992     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.117.015560     Document Type: Review

References (80)

1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-21
2. Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroendocrine interactions. Nat Rev Gastroenterol Hepatol 2010;7:163-73
3. Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H, et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012;107:262-72
4. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 2014;11:497-505
5. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006;106:1631-9
6. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765-71
7. Oku T, Nakamura S. Digestion, absorption, fermentation, and metabolism of functional sugar substitutes and their available energy. Pure Appl Chem 2002;74:1253-61
8. Spiller R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res 2016:5
9. Grembecka M. Natural sweeteners in a human diet. Rocz Panstw Zakl Hig 2015;66:195-202
10. Grembecka M. Sugar alcohols-their role in the modern world of sweeteners: a review. Eur Food Res Technol 2015;241:1-14
11. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009;30:165-74
12. Evans PR, Piesse C, Bak YT, Kellow JE. Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: relationship to enteric hypersensitivity and dysmotility. Scand J Gastroenterol 1998;33:1158-63
13. Langkilde AM, Andersson H, Schweizer TF, Wursch P. Digestion and absorption of sorbitol, maltitol and isomalt from the small bowel. A study of ileostomy subjects. Eur J Clin Nutr 1994;48:768-75
14. Mansueto P, Seidita A, D'Alcamo A, Carroccio A. Role of FODMAPs in patients with irritable bowel syndrome. Nutr Clin Pract 2015;30:665-82
15. Beaugerie L, Flourié B, Marteau P, Pellier P, Franchisseur C, Rambaud JC. Digestion and absorption in the human intestine of three sugar alcohols. Gastroenterology 1990;99:717-23
16. Bjarnason I, Peters TJ, Levi AJ. Intestinal permeability: clinical correlates. Dig Dis 1986;4:83-92
17. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactuose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probemarkers for assessment in vivo of human intestinal permeability. Clin Sci (Lond) 1986;71:71-80
18. Livesey G. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 2003;16:163-91
19. Zumbé A, Lee A, Storey D. Polyols in confectionery: the route to sugarfree, reduced sugar and reduced calorie confectionery. Br J Nutr 2001; 85 Suppl 1:S31-45
20. Patil DH, Grimble GK, Silk DB. Lactitol, a new hydrogenated lactose derivative: intestinal absorption and laxative threshold in normal human subjects. Br J Nutr 1987;57:195-9
21. Grimble GK, Patil DH, Silk DB. Assimilation of lactitol, an 'unabsorbed' disaccharide in the normal human colon. Gut 1988;29:1666-71
22. Corazza GR, Strocchi A, Rossi R, Sirola D, Gasbarrini G. Sorbitol malabsorption in normal volunteers and in patients with coeliac disease. Gut 1988;29:44-8
23. Hyams JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology 1983;84:30-3
24. Rumessen JJ, Gudmand-Hoyer E. Malabsorption of fructose-sorbitol mixtures. Interactions causing abdominal distress. Scand J Gastroenterol 1987;22:431-6
25. Rumessen JJ, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988;95:694-700
26. Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G. Metabolism of erythritol in humans: comparison with glucose and lactitol. Br J Nutr 1993;69:169-76
27. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990;99: 1016-20
28. Fernández-Bañares F, Esteve-Pardo M, de Leon R, Humbert P, Cabré E, Llovet JM, Gassull MA. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993;88:2044-50
29. Yao CK, Tan HL, van Langenberg DR, Barrett JS, Rose R, Liels K, Gibson PR, Muir JG. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet 2014;27:263-75
30. Yao CK, Tan HL, Van Langenber DR, Barrett JB, Gibson PR, Muir JG. Abnormal intestinal handling of sorbitol and mannitol in patients with IBS: mechanistic insights and potential clinical implications. J Gastroenterol Hepatol 2011;26:70
31. Menzies IS. Absorption of intact oligosaccharide in health and disease. Biochem Soc Trans 1974;2:1042-7
32. Menzies IS. Transmucosal passage of inert molecules in health and disease. In: Skadhauge E, editors. Intestinal absorption and secretion. Lancaster (United Kingdom): MTP Press; 1984. p. 527
33. Cobden I, Dickinson RJ, Rothwell J, Axon AT. Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. BMJ 1978;2:1060
34. Juby LD, Rothwell J, Axon AT. Cellobiose/mannitol sugar test-a sensitive tubeless test for coeliac disease: results on 1010 unselected patients. Gut 1989;30:476-80
35. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47: 804-11
36. Bjarnason I, O'Morain C, Levi AJ, Peters TJ. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:318-22
37. Bjarnason I, Peters TJ, Veall N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983;1:323-5
38. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001;96:1499-506
39. Horowitz L, Farrar JT. Intraluminal small intestinal pressures in normal patients and in patients with functional gastrointestinal disorders. Gastroenterology 1962;42:455-64
40. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987;92:1885-93
41. Thor P, Laskiewicz J, Konturek JW, Konturek SJ, Creutzfeldt W. Role of GIP and insulin in glucose-induced changes in intestinal motility patterns. Am J Physiol 1987;252:G8-12
42. Lin HC, Elashoff JD, Kwok GM, Gu YG, Meyer JH. Stimulation of duodenal motility by hyperosmolar mannitol depends on local osmoreceptor control. Am J Physiol 1994;266:G940-3
43. Asao T, Kuwano H, Nakamura J, Morinaga N, Hirayama I, Ide M. Gum chewing enhances early recovery from postoperative ileus after laparoscopic colectomy. J Am Coll Surg 2002;195:30-2
44. Hirayama I, Suzuki M, Ide M, Asao T, Kuwano H. Gum-chewing stimulates bowel motility after surgery for colorectal cancer. Hepatogastroenterology 2006;53:206-8
45. Gong Y, Zhang Q, Qiao L, Lv D, Ruan J, Chen H, Gong J, Shi G. Xylitol gum chewing to achieve early postoperative restoration of bowel motility after laparoscopic surgery. Surg Laparosc Endosc Percutan Tech 2015;25:303-6
46. Madsen JL, Linnet J, Rumessen JJ. Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci 2006;51:147-53
47. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56
48. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin HS, Schuster MM. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98:1187-92
49. Posserud I, Ersryd A, Simrén M. Functional findings in irritable bowel syndrome. World J Gastroenterol 2006;12:2830-8
50. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52
51. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6
52. Mearin F, Pérez-Oliveras M, Perelló A, Vinyet J, Ibañez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005;129:98-104
53. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-93
54. Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Assessment of the effect of intestinal permeability probes (lactulose and mannitol) and other liquids on digesta residence times in various segments of the gut determined by wireless motility capsule: a randomised controlled trial. PLoS One 2015;10:e0143690
55. Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995;40:1607-13
56. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 2009;146:41-6
57. Davis LM, Martinez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 2010;144:285-92
58. Bouhnik Y, Flourié B, Riottot M, Bisetti N, Gailing MF, Guibert A, Bornet F, Rambaud JC. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutr Cancer 1996;26:21-9
59. Tamura M, Hoshi C, Hori S. Xylitol affects the intestinal microbiota and metabolism of daidzein in adult male mice. Int JMol Sci 2013;14:23993-4007
60. Salminen S, Salminen E, Koivistoinen P, Bridges J, Marks V. Gut microflora interactions with xylitol in the mouse, rat and man. Food Chem Toxicol 1985;23:985-90
61. Gostner A, Blaut M, Schäffer V, Kozianowski G, Theis S, Klingeberg M, Dombrowski Y, Martin D, Ehrhardt S, Taras D, et al. Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers. Br J Nutr 2006;95:40-50
62. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl 1997;222:41-4
63. Finney M, Smullen J, Foster HA, Brokx S, Storey DM. Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology. Eur J Nutr 2007;46:307-14
64. Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156:3205-15
65. Jeffery IB, Quigley EM, öhman L, Simrén M, O'Toole PW. The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes 2012;3:572-6
66. Durbán A, Abellán JJ, Jiménez-Hernández N, Artacho A, Garrigues V, Ortiz V, Ponce J, Latorre A, Moya A. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiol Ecol 2013;86:581-9
67. Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005;43:213-22
68. Maukonen J, Satokari R, Mättö J, Söderlund H, Mattila-Sandholm T, Saarela M. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006;55:625-33
69. Pistoli S, Smejkal C, McCartney A, Gibson GR. Differences in the faecal flora of healthy individuals and patients with irritable bowel syndrome, and in vitro effects of a synbiotic upon gut flora composition. Clin Nutr 2003;22:60
70. McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, Madsen K, Bercik P, Vanner S. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2016 Mar 14 (Epub ahead of print; DOI: 10.1136/gutjnl-2015-311339)
71. Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510-8
72. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100
73. Chey WD. Food: the main course to wellness and illness in patients with irritable bowel syndrome. Am J Gastroenterol 2016;111:366-71
74. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014;146:67-75.e5
75. Kim Y, Park SC, Wolf BW, Hertzler SR. Combination of erythritol and fructose increases gastrointestinal symptoms in healthy adults. Nutr Res 2011;31:836-41
76. Koutsou GA, Storey DM, Lee A, Zumbe A, Flourie B, leBot Y, Oliver Ph. Dose-related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate. Eur J Clin Nutr 1996;50:17-21
77. Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992;27:940-4
78. Zumbé A, Brinkworth RA. Comparative studies of gastrointestinal tolerance and acceptability of milk chocolate containing either sucrose, isomalt or sorbitol in healthy consumers and type II diabetics. Z Ernahrungswiss 1992;31:40-8
79. Lee A, Zumbe A, Storey D. Breath hydrogen after ingestion of the bulk sweeteners sorbitol, isomalt and sucrose in chocolate. Br J Nutr 1994; 71:731-7
80. Oku T, Mitsuko O. Laxative threshold of sugar alcohol erythritol in human subjects. Nutr Res 1996;16:577-89